Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
390
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)

Byeong-Bae ParkDepartment of Internal Medicine, Division of Hematology/Oncology, Hanyang University College of Medicine, Seoul, Korea; ORCID Iconhttp://orcid.org/0000-0001-8794-2508
ORCID Icon,
Won Seog KimDepartment of Medicine, Division of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan, University School of Medicine, Seoul, Korea; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5400-0466
ORCID Icon,
Cheolwon SuhDepartment of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea; ORCID Iconhttp://orcid.org/0000-0002-9178-4431
ORCID Icon,
Jung Yong HongDepartment of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea; ORCID Iconhttp://orcid.org/0000-0003-1363-9332
ORCID Icon,
Deok-Hwan YangDepartment of Hemato-Oncology, Chonnam National University Hwasun Hospital, Gwangju, Korea; ORCID Iconhttp://orcid.org/0000-0003-2830-9889
ORCID Icon,
Won Sik LeeDepartment of Internal Medicine, Division of Hematology, Inje University Busan Paik Hospital, Busan, Korea; ORCID Iconhttp://orcid.org/0000-0002-7956-468X
ORCID Icon,
Young Rok DoDepartment of Medicine, Division of Hematology-Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea; ORCID Iconhttp://orcid.org/0000-0003-1631-1359
ORCID Icon,
Young Il KohDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; ORCID Iconhttp://orcid.org/0000-0002-5100-9473
ORCID Icon,
Jong-Ho WonDepartment of Internal Medicine, Soon Chun Hyang University, Seoul, South Korea; ORCID Iconhttp://orcid.org/0000-0001-6176-1442
ORCID Icon,
Min Kyoung KimDepartment of Medicine, Yeungnam University College of Medicine, Daegu, Korea; ORCID Iconhttp://orcid.org/0000-0003-0291-8512
ORCID Icon,
Jae-Cheol JoDepartment of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea; ORCID Iconhttp://orcid.org/0000-0001-6014-7977
ORCID Icon,
Shin Young HyunDepartment of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea; ORCID Iconhttp://orcid.org/0000-0002-8137-8675
ORCID Icon,
Jeong-A KimDepartment of Internal Medicine, Division of Hematology, St. Vincent’s Hospital, Catholic University of Korea College of Medicine, Suwon, Korea; ORCID Iconhttp://orcid.org/0000-0002-1993-3316
ORCID Icon,
Young Ha OhDepartment of Pathology, Hanyang University College of Medicine, Seoul, Korea; ORCID Iconhttp://orcid.org/0000-0001-8750-9843
ORCID Icon &
Seung-Sook LeeDepartment of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, KoreaORCID Iconhttp://orcid.org/0000-0001-6714-5851
ORCID Icon show all
Pages 3251-3257 | Received 13 Jan 2019, Accepted 16 May 2019, Published online: 06 Jun 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mei-ting Chen, Xiao-hong Fu, He Huang, Zhao Wang, Xiao-jie Fang, Yu-Yi Yao, Quan-Guang Ren, Ze-geng Chen & Tong-yu Lin. (2021) Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL). Leukemia & Lymphoma 62:3, pages 571-580.
Read now

Articles from other publishers (2)

Yuyang Gao, Xiaoyan Feng, Wenting Song, Hongwen Li, Cunzhen Shi, Mengyuan Jin, Zhaoming Li, Lei Zhang & Mingzhi Zhang. (2022) The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma. Hematological Oncology 40:4, pages 678-688.
Crossref
Zachary Braunstein, Miguel Ruiz, Walter Hanel, Polina Shindiapina, John C. Reneau & Jonathan E. Brammer. (2022) Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas. Journal of Personalized Medicine 12:6, pages 964.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.